Clinical trial
Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute…
NCT00184054 · University of Southern California, Other · Terminated
Key facts
| NCT number | NCT00184054 |
|---|---|
| Title | Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia |
| Official title | Phase II Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-APL Acute Myelogenous Leukemia |
| Lead sponsor | University of Southern California, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myelogenous Leukemia |
| Intervention type | Drug |
| Interventions | Arsenic Trioxide (ATO), Ascorbic Acid |
| Enrollment | 11 |
| Start date | Apr 1, 2002 |
| Primary completion | Jun 1, 2009 |
| Completion | Aug 1, 2011 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 25, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: